Chad Bousman
Title
Cited by
Cited by
Year
Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group
S Kelly, N Jahanshad, A Zalesky, P Kochunov, I Agartz, C Alloza, ...
Molecular psychiatry 23 (5), 1261-1269, 2018
3352018
Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study
J Sarris, C Stough, CA Bousman, ZT Wahid, G Murray, R Teschke, ...
Journal of clinical psychopharmacology 33 (5), 643-648, 2013
1152013
Predictors of substance use among homeless youth in San Diego
CA Bousman, EJ Blumberg, AM Shillington, MF Hovell, M Ji, S Lehman, ...
Addictive behaviors 30 (6), 1100-1110, 2005
1112005
Accelerated gray and white matter deterioration with age in schizophrenia
VL Cropley, P Klauser, RK Lenroot, J Bruggemann, S Sundram, ...
American Journal of Psychiatry 174 (3), 286-295, 2017
1032017
Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples
CA Bousman, G Chana, SJ Glatt, SD Chandler, GR Lucero, E Tatro, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153 …, 2010
962010
Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials
CA Bousman, K Arandjelovic, SG Mancuso, HA Eyre, BW Dunlop
Pharmacogenomics 20 (01), 37-47, 2019
922019
Commercial pharmacogenetic-based decision-support tools in psychiatry
CA Bousman, M Hopwood
The Lancet Psychiatry 3 (6), 585-590, 2016
902016
Genetic association studies of methamphetamine use disorders: a systematic review and synthesis
CA Bousman, SJ Glatt, IP Everall, MT Tsuang
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150 …, 2009
852009
White matter disruptions in schizophrenia are spatially widespread and topologically converge on brain network hubs
P Klauser, ST Baker, VL Cropley, C Bousman, A Fornito, L Cocchi, ...
Schizophrenia bulletin 43 (2), 425-435, 2017
842017
ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression
AB Singh, CA Bousman, CH Ng, K Byron, M Berk
Translational psychiatry 2 (11), e198-e198, 2012
832012
Evidence for network-based cortical thickness reductions in schizophrenia
CMJ Wannan, VL Cropley, MM Chakravarty, C Bousman, EP Ganella, ...
American Journal of Psychiatry 176 (7), 552-563, 2019
82*2019
Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools
CA Bousman, BW Dunlop
The pharmacogenomics journal 18 (5), 613-622, 2018
652018
Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic tools
CA Bousman, M Forbes, M Jayaram, H Eyre, CF Reynolds, M Berk, ...
BMC psychiatry 17 (1), 1-7, 2017
612017
Negative mood and sexual behavior among non-monogamous men who have sex with men in the context of methamphetamine and HIV
CA Bousman, M Cherner, C Ake, S Letendre, JH Atkinson, TL Patterson, ...
Journal of affective disorders 119 (1-3), 84-91, 2009
602009
Neuregulin-1 and schizophrenia in the genome-wide association study era
MS Mostaid, D Lloyd, B Liberg, S Sundram, A Pereira, C Pantelis, T Karl, ...
Neuroscience & Biobehavioral Reviews 68, 387-409, 2016
572016
The impact of premorbid and current intellect in schizophrenia: cognitive, symptom, and functional outcomes
R Wells, V Swaminathan, S Sundram, D Weinberg, J Bruggemann, ...
npj Schizophrenia 1 (1), 1-8, 2015
552015
Antidepressant pharmacogenetics
AB Singh, CA Bousman, C Ng, M Berk
Current opinion in psychiatry 27 (1), 43-51, 2014
552014
Early origins of mental disorder-risk factors in the perinatal and infant period
L Newman, F Judd, CA Olsson, D Castle, C Bousman, P Sheehan, ...
BMC psychiatry 16 (1), 1-8, 2016
532016
Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis
SJ Glatt, C Bousman, RS Wang, KK Murthy, BK Rana, JA Lasky-Su, ...
Drug and alcohol dependence 90 (2-3), 159-165, 2007
522007
Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting
CA Bousman, P Jaksa, C Pantelis
Pharmacogenetics and genomics 27 (11), 387-393, 2017
502017
The system can't perform the operation now. Try again later.
Articles 1–20